So many red flags in this announcement.
"The concentrations achieved were sufficient to impact bacterial growth"
Drinking a strong cup of tea is sufficient to "impact bacterial growth."
We need to see words like ERADICATE. Which clearly it didn't, given they are recycling some tired old graphs from petri dish studies rather than showing us actual data.
And the fact they are only talking about e. coli now, instead of ESKAPE pathogens....
It sounds like IV needs to be abandonded and focus completely on topical.
Ann: Phase I/II UTI/Urosepsis Rapid Infusion Trial Complete, page-22
-
- There are more pages in this discussion • 51 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RCE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
47.0¢ |
Change
0.015(3.30%) |
Mkt cap ! $104.2M | |||
| Open | High | Low | Value | Volume |
| 46.5¢ | 47.0¢ | 45.5¢ | $64.42K | 139.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 71081 | 46.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 47.5¢ | 28300 | 2 |
View Market Depth
| Last trade - 16.10pm 16/07/2024 (20 minute delay) ? |
| RCE (ASX) Chart |